Site Augmentation Services For Your Clinical Trials

Gain competitive site strength in an overcrowded clinical research landscape

How do you know if your clinical research sites are prioritizing your trial? Do you have the resources necessary to effectively run your upcoming study?

In an increasingly constrained clinical trial environment – where the demand of clinical trial volume and complexity has outpaced the supply of principal investigator participation – sites can no longer sustainably support clinical research. 

And yet, leading sponsors and CROs are charting the path to attain more focused trial coverage, long-lasting site relationships, and an edge over their competitors using WCG Site Augmentation.

Deliver the resource flexibility of Site Augmentation before your trials are impacted

Through our Site Augmentation capabilities, we ensure that study teams have the support they need to mitigate site staffing shortages and constraints.

How? By deploying our highly trained clinical research professionals to meet your exact study, indication, molecule, or full therapeutic portfolio needs.

On the demand side…

…trials have swelled in volume and complexity over the last 10 years: For Phase III trials, the number of clinical endpoints has increased by 86% while required procedures have increased by 70%. These growing challenges require more staff and more scientifically integrated technology.

On the supply side…

…trial growth is outpacing site capacity:

• Sites are underfunded: Hospital revenues are down, and the average profit margin at sites has dropped 38%.
• Sites are understaffed: Healthcare employment has dropped precipitously during the pandemic. And in Spring of 2021, workforce shortages at hospitals and health systems widened with the number of healthcare and social assistance job openings rising to 1,319,000 from 1,287,000 in March.
• Only 3% of physicians participate in clinical trials.
• New investigator participation has dropped 48% in the last five years.